HUM vs. GEHC, ALC, HLN, CNC, IDXX, RMD, TAK, BIIB, IQV, and MRNA
Should you be buying Humana stock or one of its competitors? The main competitors of Humana include GE HealthCare Technologies (GEHC), Alcon (ALC), Haleon (HLN), Centene (CNC), IDEXX Laboratories (IDXX), ResMed (RMD), Takeda Pharmaceutical (TAK), Biogen (BIIB), IQVIA (IQV), and Moderna (MRNA). These companies are all part of the "medical" sector.
Humana (NYSE:HUM) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation, community ranking and profitability.
GE HealthCare Technologies has a net margin of 8.02% compared to Humana's net margin of 1.82%. GE HealthCare Technologies' return on equity of 25.58% beat Humana's return on equity.
Humana currently has a consensus price target of $424.50, suggesting a potential upside of 33.84%. GE HealthCare Technologies has a consensus price target of $95.00, suggesting a potential upside of 21.39%. Given Humana's higher possible upside, research analysts plainly believe Humana is more favorable than GE HealthCare Technologies.
In the previous week, Humana had 30 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 61 mentions for Humana and 31 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 0.42 beat Humana's score of 0.29 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.
Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.1%. GE HealthCare Technologies pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Humana pays out 22.0% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 4.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Humana has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500.
92.4% of Humana shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of Humana shares are owned by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Humana received 869 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 64.15% of users gave Humana an outperform vote while only 53.57% of users gave GE HealthCare Technologies an outperform vote.
Humana has higher revenue and earnings than GE HealthCare Technologies. Humana is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Humana beats GE HealthCare Technologies on 12 of the 20 factors compared between the two stocks.
Get Humana News Delivered to You Automatically
Sign up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
